Campbells acted as Cayman Islands and British Virgin Islands legal counsel to Honliv Healthcare Management Group Company Limited (宏力醫療管理集團有限公司)(“Honliv Healthcare”) in connection with its HK$315 million (US$40.5 million) (and up to HK$362 million (US$46.5 million) upon exercise of the over-allotment option) initial public offering on the Main Board of the Hong Kong Stock Exchange.
O’Melveny & Myers and Commerce & Finance Law Offices acted as Hong Kong and PRC legal counsel, respectively, to Honliv Healthcare. Fangda Partners and Jingtian & Gongcheng acted as Hong Kong and PRC legal counsel, respectively, to BOCOM International (Asia) Limited (being the sole sponsor) and the underwriters (including BOCOM International Securities Limited, CMB International Capital Limited, Sheng Yuan Securities Limited, Huatai Financial Holdings (Hong Kong) Limited, Goldbridge Securities Limited, Haitong International Securities Company Limited, ABCI Securities Company Limited, AMTD Global Markets Limited, Zhongtai International Securities Limited, Tianda Securities Limited, HTF Securities Limited and Sinomax Securities Limited).
Honliv Healthcare operates one of the largest for-profit private general hospitals in China, Henan Honliv Hospital. Among all the for-profit private general hospitals in China, Honliv Healthcare’s hospital ranked third in terms of number of beds in operation as of December 31, 2019. Operating since December 2006, Honliv Healthcare’s hospital is the first for-profit private general hospital established in Henan Province and one of the first few large private general hospitals in China focusing on the county-level healthcare services market.
